Infection with Influenza A Virus Leads to Flu Antigen-Induced Cutaneous Anaphylaxis in Mice  by Grunewald, Susanne M. et al.
Infection with In¯uenza A Virus Leads to Flu Antigen-
Induced Cutaneous Anaphylaxis in Mice
Susanne M. Grunewald, Christian Hahn, Gisela Wohlleben,* Martin Teufel, Tamas Major,* Heidrun Moll,*
Eva-B. BroÈcker, and Klaus J. Erb*
Klinik und Poliklinik fuÈr Haut- und Geschlechtskrankheiten, UniversitaÈt WuÈrzburg, WuÈrzburg, Germany; *Institut fuÈr Molekulare Infektionsbiologie
und Zentrum fuÈr Infektionsforschung, UniversitaÈt WuÈrzburg, WuÈrzburg, Germany
It is well established, that viral infections may trigger
urticaria or allergic asthma; however, as viral infec-
tions induce T helper 1 polarized responses, which
lead to the inhibition of T helper 2 cell development,
the opposite would be plausible. We wanted to
investigate how viral infections may mediate allergic
symptoms in a mouse model; therefore, we infected
BALB/C mice with in¯uenza A virus intranasally.
Histologic analyses of lung sections and bronchoal-
veolar lavages were performed. In addition, cells
from the mediastinal lymph nodes were restimulated
in vitro to analyze which types of cytokines were
induced by the ¯u infection. Furthermore, ¯u-spe-
ci®c antibody titers were determined and local ana-
phylaxis was measured after rechallenge with ¯u
antigen. We found that airways in¯ammation con-
sisted predominately of macrophages and lympho-
cytes, whereas only a few eosinophils were observed.
interferon-g but no interleukin-4 and little interleu-
kin-5 could be detected in the culture supernatants
from in vitro restimulated T cells from the draining
lymph nodes. The antibody response was character-
ized by high levels of virus-speci®c IgG2a, IgG2b,
and IgG1 and, surprisingly, low levels of virus-spe-
ci®c IgE antibodies. Interestingly, ¯u-infected mice
developed active and passive cutaneous anaphylaxis
after rechallenge with ¯u-antigen. As the passive
cutaneous anaphylaxis reaction persisted over 48 h
and was signi®cantly lower after passive transfer of
the serum, which was IgE depleted, local anaphylaxis
seemed to be mediated predominately by speci®c
IgE antibodies. Taken together, our results demon-
strate that mice infected with ¯u virus develop virus-
speci®c mast cell degranulation in the skin. Our
results may also have implications for the pathogen-
esis of urticaria or other atopic disorders in humans.
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A
topic disorders are the result of T helper (Th) 2-
dominated immune responses towards antigens lead-
ing to eosinophilia and the production of allergen-
speci®c IgE antibodies, which induce mast cell
degranulation following challenge with the relevant
allergens (Parronchi et al, 2000). In contrast, viral infections
generally induce strong Th1-dominated immune responses with
large amounts of interferon (IFN)-g produced. IFN-g in turn has
been shown to be a strong inhibitory factor for the development of
allergen-speci®c Th2 cells (Gajewski et al, 1988). For this reason it
has been proposed that viral infections should inhibit the
development of atopic disorders (Erb, 1999; Herz et al, 2000).
Interestingly, the opposite seems to be true as viral infections are
clinically associated with the development of acute urticaria or the
exacerbation of asthma and atopic dermatitis (Mortureux et al,
1998; Sakurai et al, 2000; Lester and Schneider, 2000; Gern and
Busse, 2000).
How can infections that induce strong Th1 immune responses
exacerbate allergic disease? Several mechanisms have been proposed
addressing this very interesting question in respect to virus
infections of the respiratory tract. For example, epithelial injury
may sensitize cholinergic afferent ®bers and diminish b-adrenergic
®bers leading to acute bronchial hyper-responsiveness (Corne and
Holgate, 1997). Furthermore, the in¯ammatory Th1 response in
the lung (induced by the virus), through the induction of
proin¯ammatory cytokines and chemokines such as IFN-g,
interleukin (IL)-8, and RANTES, may exacerbate the allergic
disorder by increasing an in¯ux of in¯ammatory cells into the lung
(van Schaik et al, 1999; Lacy et al, 1999; Olszewska-Pazdrak et al,
1998; Herz et al, 2000; Johnston et al, 1998; Harrison et al, 1999).
Taken together, the clinical observations and experimental data
clearly suggest that viral infections, which induce Th1 responses,
can under certain conditions exacerbate atopic disorders (Herz et al,
2000); however, in some patients viral infections seem to induce
allergic reactions directly. The most prominent example is the
induction of acute urticaria shortly after viral infections, especially
in children (Mortureux et al, 1998). How can this occur? A possible
explanation is, that viral infections not only induce a Th1 but also a
minor Th2 response leading to the production of virus-speci®c IgE
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antibodies. Bound to mast cells, virus-speci®c IgE could directly
induce mast cell degranulation when encountering viral antigen,
thereby causing urticaria; however, it is still unclear if and to what
extent viruses can directly induce Th2 responses in humans, and if
the small amounts of virus-speci®c IgE detected in some patients
after infection (Gern and Busse, 2000), can lead to the degranula-
tion of mast cells.
To address this question, we infected mice with in¯uenza A virus
and analyzed in detail the resulting Th1- and Th2-type responses.
We show here, that the immune response against in¯uenza A virus
was strongly dominated by Th1 responses and virus-speci®c
antibodies of the IgG1, IgG2a, and IgG2b subtypes; however,
infected mice also produced virus-speci®c IgE antibodies and
showed local anaphylaxis after rechallenge with the in¯uenza A
virus antigen (Flu-Ag).
MATERIALS AND METHODS
In¯uenza A virus and infection of mice The HKx31 (H3N2)
in¯uenza A virus was grown in the allantoic ¯uid of 10 d old
embryonated eggs. Female BALB/C and C57/BL6 mice were purchased
from Charles River (Sulzfeld, Germany) and were maintained under
conventional conditions in an isolation facility. At the onset of the
experiments, all animals were between 6 and 8 wk of age. Mice were
anesthetized by intraperitoneal (i.p) inoculation with Avertin (2,2,2,-
tribromoethanol) and infected intranasally with 30 ml of phosphate-
buffered saline (PBS) containing 2 3 105 EID50 (egg infectious dose
50%) of the HKx31 in¯uenza A virus. All experiments were performed
according to the guidelines for the care and use of experimental animals
prepared and published by the Society for Laboratory Animal Sciences
(GV-SOLAS, Biberach an der Riss, Germany), 1988.
Ovalbumin sensitization BALB/C mice were anesthetized by i.p.
injection of ketamine and xylazaine (Sigma Deisenhofen, Germany), and
50 mg ovalbumin grade V (Sigma) in 50 ml PBS was administered
intranasally a total of six times at 1 wk intervals as described (Nelde et al,
2001). Subsequently, mice were rechallenged intranasally 1 d after the
last ovalbumin sensitization and 24 h later mice were killed and the
resulting immune response analyzed.
Histologic analysis Lung tissues were ®xed in 10% phosphate-
buffered formalin for at least 24 h and embedded in paraf®n wax.
Sections (2±3 mm) were cut and stained with hematoxylin and eosin.
The stained sections were visualized by light microscopy.
Bronchoalveolar lavages (BAL) At different time points after
infection with in¯uenza A virus, or after the ®nal intranasal application
of ovalbumin, mice were killed, the trachea cannulated, and BAL
performed by ¯ushing lung and airways three times with 1 ml PBS. BAL
cells were counted, and spun on to glass slides using a cytospin, followed
by staining with Dif-Quik (Dade, Marburg, Germany). Total cell counts
and number of macrophages, lymphocytes, eosinophils, and neutrophils
were determined microscopically using standard cytologic criteria.
Cell culture conditions and enzyme-linked immunosorbent assay
(ELISA) used for the detection of cytokines Single-cell suspensions
from the mediastinal lymph nodes (MLN) were prepared by teasing the
MLN through a steel mesh and discarding the cell debris. Culture
medium was IMDM (Sigma, St Louis, MO) supplemented with 10 mM
HEPES, 2 mM L-glutamine, 1% nonessential amino acids, 1 mM
sodium pyruvate, 50 mg gentamycin per ml, 50 mM 2-mercaptoethanol,
and 10% fetal bovine serum. Total MLN cells (2 3 106 cells per ml)
were left in medium alone or stimulated in microwells coated with
either a monoclonal antibody to CD3 (145±2C11; 25 mg per ml) in the
presence of 50 U per ml recombinant human IL-2 (Novartis, Basel,
Switzerland) puri®ed Flu-Ag (40 mg per ml) (SPAFAS, North Franklin,
CT) or ovalbumin (100 mg per ml; Sigma). Supernatants were harvested
48 h later (in some experiments supernatants were also collected at 24
and 72 h). For the detection of IFN-g, IL-4, and IL-5 in the cell culture
supernatants, sandwich ELISA with the following monoclonal antibodies,
recognizing two different epitopes of the respective lymphokines, were
used: biotinylated rat anti-mouse IFN-g (AN-18.17.24) and
unconjugated rat anti-mouse IFN-g (R4±6A2); biotinylated rat anti-
mouse IL-5 (TRFK4) and unconjugated rat anti-mouse IL-5 (TRFK5);
biotinylated rat anti-mouse IL-4 (BVD6±24G2) and unconjugated rat
anti-mouse IL-4 (BVD4±1D11; all antibodies were purchased from
Pharmingen, San Diego, CA). The assays were performed in polyvinyl
chloride microtiter plates (Dynatech, Denkendorf, Germany) according
to instructions from the monoclonal antibody manufacturer. The binding
reactions were visualized with a conjugate of biotin±streptavidin±alkaline
phosphatase (Dako, Denmark) and the phosphatase substrate 104 from
Sigma. Absorbance was read at 414 nm in an ELISA microplate reader
(Anthos Hill, Salzburg, Austria). For quanti®cation of the cytokines in
the culture supernatants, titrations were performed with murine
recombinant IFN-g, recombinant IL-4, and recombinant IL-5
(Pharmingen).
Detection of in¯uenza A virus and ovalbumin speci®c
immunoglobulin in the serum of mice IgE and IgG speci®c for
in¯uenza A virus or ovalbumin were measured by ELISA. For the
detection of IgG1, IgG2a, and IgG2b the plates were coated with 10 mg
Flu-Ag per ml coating buffer (100 mM NaCO3 pH 8.5). For the
detection of ¯u-speci®c IgE 100 mg Flu-Ag per ml coating buffer was
used. For the detection of ovalbumin-speci®c IgG1 and IgE the plates
were coated with 100 mg per ml of ovalbumin (Sigma) in coating buffer.
Plates were blocked with 10% bovine serum albumin in PBS containing
0.05% Tween 20 (Sigma), and 100 ml of serial serum dilutions in PBS
containing 0.05% Tween 20 and 1% bovine serum albumin were applied
overnight at 4°C. Antibody binding was analyzed using biotinylated
monoclonal antibodies against mouse IgG1, IgG2a, IgG2b, or IgE as
described above (monoclonal antibodies purchased from Pharmingen).
Serum titers are expressed as the reciprocal value of the serum dilutions,
which were 2-fold over background optical density (OD414) of age-
matched noninfected mice (for the virus-speci®c IgG the OD was
measured at a serum dilution of 1/100 and for virus-speci®c IgE a 1/4
serum dilution)
Depletion of IgE from the serum of infected mice Mice were
infected with ¯u virus for 3 wk, killed, and serum collected. To deplete
the IgE, pooled serum (10 mice) was incubated on anti-IgE-coated
microtiter plates. The plates were coated (100 ml per well) with 2 mg
per ml anti-IgE monoclonal antibody (Pharmingen) in coating-buffer
(100 mM NaCO3 pH 8.5) o.n. Plates were blocked with 10% bovine
serum albumin in PBS containing 0.05% Tween 20 (Sigma). After
washing, 100 ml of serum was added to the wells. After 30 min the
serum was transferred to a new anti-IgE coated well. This was repeated
until total IgE was reduced from 550 ng per ml before to 20 ng per ml
after the depletion of IgE. Total IgG1 serum levels were not signi®cantly
altered (258 mg per ml serum before 380 mg per ml after depletion of
IgE). The ELISA for the detection of serum IgE and IgG1 were
performed as previously described (Erb et al, 1999).
Active and passive cutaneous anaphylaxis Active cutaneous
anaphylaxis was tested 3 wk after in¯uenza infection. BALB/C and C57/
BL6 mice were injected i.v. with 200 ml 0.5% Evans Blue in PBS
(Sigma). Subsequently the skin of the belly was shaved and 50 ml PBS
containing 500 mg per ml in¯uenza antigen or PBS alone was injected
intradermally into two premarked sites on the skin. After 15 min, mice
were killed and the skin was stripped off. Positive reactions towards virus
antigen resulted in mast cell degranulation and ¯uid extravasation, which
led to the formation of a blue patch around the injection site. The
intensity of bluing as an indicator for the intensity of mast cell
degranulation was scored by two independent observers (0 = no bluing,
1 = slight bluing, 2 = strong bluing; Grunewald et al, 1998).
For detection of passive cutaneous anaphylaxis serum of noninfected
control mice or ¯u-infected mice was collected 3 wk after infection and
pooled. A part of the in¯uenza serum was depleted from IgE antibodies
as described above. Subsequently, groups of noninfected mice were
injected intradermally with 50 ml of the various serum pools at a 1:5
dilution into premarked sites on the shaved belly. Cutaneous anaphylaxis
was measured in the sites of previous serum injection 2, 24, and 48 h as
described above.
Statistical analysis Statistical signi®cance was analyzed by the Mann±
Whitney U test. Values of p < 0.05 were considered statistically
signi®cant.
RESULTS
Infection with in¯uenza A virus induces strong airways
in¯ammation dominated by macrophages, lymphocytes,
and neutrophils BALB/C mice were infected with ¯u virus
intranasally and the resulting in¯ammation in the lung tissue was
analyzed histologically. For this purpose, lung sections were
prepared before and 7, 14, and 21 d after infection and were
stained with hematoxylin and eosin. The results revealed, that mice
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infected with ¯u virus for 1 wk showed massive perivascular
in®ltrates and interstitial edema in comparison with noninfected
mice. After 3 wk the interstitial edema has cleared but the
perivascular in®ltrate could still be detected (data not shown).
To analyze the cellular composition of the in¯ammatory
in®ltrates in more detail BAL were performed and the amount of
the different cell types present in the BAL determined. In
agreement with the histologic examinations Fig 1 shows, that
total cell counts in the lavage ¯uids were highest 1 wk after
infection and then gradually decreased over the next 2 wk. In
comparison with uninfected controls the infected mice show a
strong increase in total number of lymphocytes, macrophages, and
neutrophils present in the lung. Very few eosinophils could also be
detected 1 wk after infection (Fig 1) but not 3 and 5 d after
infection (data not shown).
Infection of mice with ¯u virus results in a Th1-dominated
immune response with a minor Th2 component To study
the cytokine pro®le of T lymphocytes in the lung, single cell
suspensions of the MLN were prepared at different time points after
¯u virus infection and left in medium alone or restimulated with
Flu-Ag or anti-CD3/IL-2 in vitro. MLN cells from uninfected mice
were also included as controls. The supernatants were collected
48 h later and the presence of IFN-g, IL-5, and IL-4 determined by
ELISA. Figure 2 shows that T cells from the MLN produce the
most IFN-g after 1 wk of infection, both after antigen-speci®c and
polyclonal anti-CD3/IL-2 restimulation. Antigen-speci®c IFN-g
production could also be detected 2 and 3 wk after infection.
Similar results were obtained, when analyzing the amounts of IFN-
g present in the supernatants 24 h and 72 h after the different
stimulations (data not shown). Furthermore, only low levels of IL-4
(after 24 h) and IL-5 (after 72 h) could be detected after anti-CD3/
IL-2 stimulation, with no difference between the amounts of IL-4
and IL-5 being produced by the MLN cells from infected vs
uninfected mice. No IL-4 could be detected after stimulation with
Flu-Ag in any of the cultures (data not shown); however, low levels
of antigen-speci®c IL-5 production could be detected in the
supernatants of the MLN from 2 wk infected mice 72 h after
restimulation with Flu-Ag (data not shown). Taken together, these
results suggest that beside a strong Th1 dominated immune
response only small numbers of Th2 cells were generated during
the ¯u infection in the lung.
To investigate, whether the B cell response against ¯u virus in
the lung is also strongly biased towards Th1, we determined
¯u-virus speci®c antibody titers in the serum. As expected, the
Th1-associated virus-speci®c IgG2a and IgG2b titers showed a
strong increase during the ¯u infection (Fig 3). The same was true
for the virus-speci®c IgG1, which is associated with Th2 responses.
Surprisingly, virus-speci®c IgE antibodies could also be detected.
They were induced to 100±1000-fold lower levels than the IgG
subtypes but showed a clear kinetic peak 2 wk after infection
(Fig 3). These results clearly suggest, that the humoral immune
response against in¯uenza A virus is also Th1 dominated but has a
clear Th2 component.
Next we felt it to be important to investigate how strong the
minor Th2 responses against ¯u virus is in comparison with an
antigen known to induce strong Th2 responses. For this reason
BALB/C mice were immunized intranasally with ovalbumin
(see Materials and Methods). One day after the last intranasal
ovalbumin application mice were killed and the Th2 response
against ovalbumin was analyzed and compared with the
maximal Th2 responses detected in ¯u-infected mice.
Eosinophil numbers after ovalbumin sensitization in the BAL
were 7-fold higher than the maximum amounts of eosinophils
detected in the BAL after a ¯u infection [7.5 3 104 per
ml 6 6.3 (n = 7) vs 1.04 3 104 per ml 6 0.4 (n = 6)]. The
levels of ovalbumin-speci®c IL-5 secretion by MLN stimulated
with ovalbumin for 48 h was also 10-fold higher than the
maximum amount of ¯u-speci®c IL-5 production measured
72 h after restimulation of MLN cells from 2 wk ¯u-infected
mice [250 pg per ml 6 210 (n = 6) vs 23 pg per ml 6 11
(n = 4)]. Interestingly, ¯u-antigen induced IFN-g secretion by
the MLN from infected mice could easily be detected (see
Fig 2), whereas no IFN-g could be detected in the supernatants
of the MLN from ovalbumin-treated mice 48 h after in vitro
stimulation with ovalbumin (n = 6). Furthermore, ovalbumin
speci®c IgG1 and IgE serum levels were also at least 8-fold
higher than the maximum ¯u speci®c IgG1 and IgE titers
detected when using a similar ELISA design (data not shown).
Although it is dif®cult to directly compare the immune
response in the lung initiated against ¯u virus (strong anti-
infectious response) with the response initiated after consecutive
intranasal applications of ovalbumin, it is clear that the Th2
response against ¯u virus is a relative weak Th2 response in
comparison with the Th2 response initiated after the intranasal
application of ovalbumin. In addition, the immune response
against ovalbumin is clearly biased towards Th2, whereas the
Figure 1. Infection of mice with ¯u virus
induces a strong in¯ux of lymphocytes,
macrophages, and neutrophils but recruits
only few eosinophils into the lung. At the
indicated time points after infection, BAL were
performed. BAL cells were counted, and spun
onto glass slides using a cytospin, followed by
staining with Dif-Quik. Mean cell counts 3 104
per ml BAL ¯uid of the different cell types from
six to seven individual mice per group with SD is
shown (*statistical signi®cance in comparison with
uninfected controls).
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response against ¯u virus is dominated by ¯u-speci®c Th1
responses.
Virus antigen induces local anaphylaxis in mice Next we
asked whether the virus-speci®c antibodies could elicit allergic
symptoms in mice following virus antigen challenge. Therefore, we
investigated whether mice that had been infected for 3 wk
developed active cutaneous anaphylaxis after the application of
Flu-Ag. For this purpose, mice were ®rst injected i.v. with Evans
Blue dye and then with Flu-Ag and PBS intradermally into two
separate premarked sites in the skin. After 15 min, mast cell
degranulation induced the extravasation of ¯uid, which led to the
formation of a blue patch around the injection site of virus antigen
only in infected mice (Fig 4A). The lack of this blue patch
formation in noninfected mice indicates the lack of mast cell
degranulation after virus antigen challenge. Figure 4B shows mean
bluing intensities in groups of noninfected vs infected mice at the
site of Flu-Ag. After intradermal Flu-Ag injection, mice that had
been infected with ¯u virus showed a much stronger mast cell
degranulation than noninfected control animals.
As in mice, both IgE and IgG1 antibodies have been shown to
induce cutaneous anaphylaxis (Oshiba et al, 1996), we investigated
if the allergic reactivity after Flu-Ag rechallenge in infected mice
was mediated by virus-speci®c IgE antibodies or only by virus-
speci®c IgG1 antibodies. Furthermore, we wanted to exclude that
virus-induced alterations of mast cell reactivity may be responsible
for the local anaphylaxis reaction in infected mice. Therefore, we
passively transferred serum of infected mice into noninfected mice
and checked for passive cutaneous anaphylaxis. For this purpose,
groups of noninfected mice were injected intradermally with 50 ml
serum from mice, which had been infected with ¯u virus for 3 wk.
Two, 24, and 48 h later local anaphylaxis was measured at the sites
of the previous serum injections as described above. Figure 5
shows, that the intradermal virus antigen challenge induced similar
mast cell degranulation in mice, which had been injected 2, 24, and
48 h earlier with the serum from 3 wk infected mice. In contrast,
the passive cutaneous anaphylaxis reaction was signi®cantly lower
in mice that were treated with IgE depleted serum from ¯u-
infected mice or with sera of noninfected mice. Taken together,
the persisting local anaphylaxis reaction 48 h after serum injection
(Lehrer, 1977) and the strong reduction of mast cell degranulation
after IgE depletion indicates that virus-speci®c IgE antibodies were
mediating allergic skin reactivity.
Next we investigated, if C57/BL6 mice infected with ¯u virus
also developed active cutaneous anaphylaxis after the application of
Flu-Ag. For this purpose, mice were treated as described above and
cutaneous reactivity scored as described in the legend to Fig 4. As
expected we found, that noninfected C57/BL6 mice showed no
bluing in the skin after intradermal challenge with ¯u-antigen
(average bluing intensity of 0; n = 2). In contrast, 3 wk infected
mice showed a clear bluing in the skin after the intradermal
application of ¯u-antigen [average bluing intensity of 1.2 6 0.75
(n = 8)]. This shows that C57/BL6 mice also develop active
cutaneous anaphylaxis after ¯u infection and indicates, that this is a
Figure 2. MLN cells obtained from the lungs of mice previously
infected with ¯u virus show a strong production of IFN-g, after
in vitro restimulation with Flu-Ag or anti-CD3 in combination
with IL-2. At the indicated time points after infection MLN cells were
prepared and cultured in medium alone or restimulated with Flu-Ag or
anti-CD3/IL-2 in vitro. MLN cells from uninfected mice were included
as controls. The supernatants were collected 48 h later and the presence
of IFN-g was determined by ELISA. Shown are the mean amounts of
IFN-g from ®ve to six mice per group with SD (*statistical signi®cance
in comparison with uninfected controls).
Figure 3. Mice show a strong increase in ¯u-speci®c IgG2a,
IgG2b, and IgG1 in the serum after ¯u infection, but also low
levels of virus-speci®c IgE. Mice were infected with ¯u virus and the
serum collected at the indicated time points after infection. Serum titers
for virus-speci®c IgG2a, IgG2b, IgG1, and IgE were determined by
ELISA. Shown are the mean reciprocal values with SD of the serum
dilutions, which were 2-fold over the background OD of noninfected
mice (six mice per group).
648 GRUNEWALD ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
general phenomenon in mice and not only limited to the BALB/C
strain.
DISCUSSION
The results presented in this study clearly indicate that the immune
response against in¯uenza A virus in BALB/C mice is strongly
polarized towards Th1 but also has a minor Th2 component. This
can be seen by the large amounts of IFN-g, the absence of IL-4, and
the low levels of IL-5 secreted by the MLN cells after in vitro
restimulation with Flu-Ag or anti-CD3. The small numbers of
eosinophils detected in the lung after infection together with the
low titers of ¯u-speci®c IgE in the serum of infected mice further
supports this view.
Interestingly, we could show that mice infected with ¯u virus
developed virus-speci®c IgE antibodies and active cutaneous
anaphylaxis after intradermal injection with Flu-Ag. Passive
cutaneous anaphylaxis could also be demonstrated, suggesting that
the detected virus-speci®c immunoglobulins and not virus-induced
alterations of mast cell reactivity were mediating this effect. The
passive cutaneous anaphylaxis reaction is a well established method
to demonstrate antibody-mediated mast cell degranulation in the
skin (Ovary and Warner, 1972; Lehrer, 1977). It had been shown
that after passive transfer of serum both IgE and IgG1 can bind on
to mouse mast cells; however, IgG1 antibodies are rapidly cleared
from mast cell receptors, whereas IgE antibodies persist for long
periods of time. Therefore, IgG1-mediated passive cutaneous
anaphylaxis reactions may be detected only 2 h after serum transfer,
whereas IgE-mediated mast cell degranulation can be detected 48 h
later (Ovary and Warner, 1972; Lehrer, 1977). Our observation
that in ¯u-infected mice speci®c IgG1 titers were much higher than
the speci®c IgE titers, together with the published ®nding that local
as well as systemic anaphylaxis can occur in the absence of IgE
(Oettgen et al, 1994; Oshiba et al, 1996), suggested that IgG1 may
be mediating the allergic skin reactivity. We could show, however,
that passive transfer of IgE depleted ¯u serum strongly reduced the
allergic skin reactivity and that the local anaphylaxis reaction
persisted 48 h after passive transfer of serum, indicating that mast
cell degranulation was mainly mediated by virus-speci®c IgE. This
view is supported by data of Faquim-Mauro et al (1999), showing
that IL-4 and IL-12 differentially induce the production of two
distinct subtypes of IgG1, which are either inducers or noninducers
of passive cutaneous anaphylaxis in mice, respectively. As BALB/C
mice infected with ¯u virus show such a strong Th1 response, one
would expect predominately the IL-12-induced nonanaphylactic
IgG1 subtype to develop. Interestingly, mice that had been infected
with ¯u virus for 3 wk did not show any signs of systemic
anaphylactic symptoms after i.v. challenge of up to 200 mg of virus
antigen (data not shown), indicating that the low amounts of virus-
speci®c IgE antibodies are high enough to mediate local but not
systemic allergic symptoms. As speci®c IgG1 antibodies were
present in large amounts at an average serum titer of 1:86,000, the
lack of systemic anaphylaxis in ¯u-infected mice further supports
the predominate role of speci®c IgE and not IgG1 for virus speci®c
mast cell degranulation. Taken together, our observations strongly
suggest that virus-speci®c IgE were mediating allergic skin
reactivity, however, we cannot completely rule out that speci®c
IgG1 antibodies or, although unlikely, other as of yet unidenti®ed
serum factors may also be contributing to the observed active and
passive anaphylaxis. Furthermore, in view of the allergen-speci®c
immunotherapy used in humans, it may be important to note that
cutaneous anaphylaxis occurred even though large amounts of
virus-speci®c IgG1 (presumed not to cause mast cell degranulation;
Faquim-Mauro et al, 1999), IgG2a, and IgG2b were present.
Our ®nding, that Th1 dominated immune responses such as
infections with in¯uenza A virus and the development of Th2
driven allergic responses are not mutually exclusive is underlined by
several other studies. It could be shown that respiratory syncytial
virus and in¯uenza A virus infection increased ovalbumin-speci®c
IgE production and airways responsiveness in ovalbumin-exposed
mice (Schwarze et al, 1997; Suzuki et al, 1998). Yamamoto et al
(2000, 2001) could show that dendritic cells were associated with
the augmentation of antigen sensitization by in¯uenza A virus and
that the induced allergen speci®c immune response was dependent
on the timing after ¯u infection. The enhanced sensitization to
Figure 4. Mice infected with ¯u virus show Flu-Ag-speci®c active cutaneous anaphylaxis. Active cutaneous anaphylaxis was tested in
uninfected mice or in mice that had been infected for 3 wk with ¯u virus. Mice were injected i.v. with Evans Blue Dye. Subsequently the skin of the
belly was shaved and Flu-Ag or PBS was injected intradermally into the skin. After 15 min the intensity of bluing as an indicator for the intensity of
mast cell degranulation was scored as follows: 0 = no bluing, 1 = slight bluing, 2 = strong bluing. (A) Representative example of the bluing obtained
in the skin of control mice and mice infected for 3 wk with ¯u virus. (B) Average bluing intensity with SD of the different groups of mice after active
cutaneous anaphylaxis (10 mice per group; *statistical signi®cance in comparison with uninfected controls).
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aeroallergens after viral infections may partially be due to direct
injury of the airways epithelium during an respiratory infections,
which may facilitate the entrance of aeroallergens (O'Donnell and
Openshaw, 1998; Suzuki et al, 1998); however, viruses have also
been reported to stimulate Th2 responses by enhancing mast cell
degranulation. Clementsen et al (1990) could show in vitro that
in¯uenza A virus caused a synergistic enhancement of mediator
release from basophils following stimuli such as anti-IgE, antigen,
or calcium ionophore A23187. This effect could be abolished by
blockade of viral neuraminidase and hemagglutinin (Clementsen et
al, 1989); however viral antigens could not yet be shown to induce
histamine release per se.
Although it is generally assumed that infections with bacteria or
viruses and vaccinations induce Th1 reactions, there is some
evidence that mixed Th1 and Th2 responses occur in humans as
well. The development of speci®c IgE antibodies directed against
bacterial antigens had been shown after booster immunization with a
cellular diphtheria tetanus pertussis vaccine, which enhanced Th2
cytokine production, speci®c IgE antibody production, and local
reactions to pertussis toxin (Edelman et al, 1999; Ryan et al, 2000).
Furthermore, in patients with chronic bronchitis basophil bound IgE
and serum IgE directed against Haemophilus in¯uenzae and
Streptococcus pneumoniae was found during acute exacerbations
(Kjaergard et al, 1996). In addition, the development of virus-
speci®c IgE also seems not to be limited to mice, as some viruses have
been shown to induce virus-speci®c IgE antibodies in humans.
Welliver et al (1981, 1982) demonstrated, that patients developed
virus-speci®c IgE antibodies both after respiratory syncytial virus and
parain¯uenza virus infection. Furthermore, the appearance of virus-
speci®c IgE antibodies could be correlated with croup and wheezing
in patients suffering from an infection with the parain¯uenza virus
(Welliver et al, 1982; Gern and Busse, 2000). Our data and the
studies discussed above support the idea, that speci®c IgE antibodies
directed against viral or bacterial antigens may be important for
infection-associated induction or exacerbation of atopic disease.
Although the appearance of speci®c IgE antibodies directed against
viral or bacterial substances could be correlated with bronchial
hypersensitivity (Welliver et al, 1982; Kjaergard et al, 1996) little is
known about the correlation of virus-speci®c IgE antibodies and the
induction of urticaria or atopic dermatitis.
One possibility is, that the IgE bound to mast cells may directly
cause mast cell degranulation after encountering viral antigen in the
skin or the lung during or shortly after the infection. Our data
supports this hypothesis. It is also possible, however, that the
appearance of virus-speci®c IgE may not be relevant for the
induction/exacerbation of urticaria or atopic disease and that other
mechanisms are responsible for the observed immunologic phe-
nomenon. One such mechanism may be molecular mimicry. Viral
antigens may cross-react with pre-existing IgE antibodies bound to
mast cells of other speci®city (house dust mite, pollen, etc.) thereby
causing the exacerbation of Th2 responses. In patients suffering
from pollen-associated food allergies epitope cross-reactivity is also
believed to be responsible for the development of urticaria. It has
been suggested that birch pollen-speci®c IgE either cross-reacts
with antigens, carbohydrate determinants, or lectins from the
carrots or fruits leading to mast cell degranulation and the induction
of urticaria (Caballero and Martin-Esteban, 1998; Ebner et al, 1995,
1996). Furthermore, virus-induced urticaria may also be explained
by an intolerance-like reaction, where the viral infection directly
leads to the degranulation of mast cells through IgE independent
mechanisms (Church and Levi-Schaffer, 1997). A further possibility
of how viruses may exacerbate allergic Th2 responses is by simply
inducing a strong speci®c and/or nonspeci®c in¯ammatory
response. This view is supported by several studies. First, children
with virus-induced asthma were found to exhibit an increase in
IFN-g in respiratory secretions (van Schaik et al, 1999). IFN-g in
turn has been shown to increase the secretion of RANTES from
eosinophils (Lacy et al, 1999), which subsequently may lead to
stronger allergic in¯ammation, as RANTES is associated with
increased Th2 cell in¯ux and eosinophilia (Homey and Zlotnik,
1999). Furthermore, respiratory syncytial virus infections of
bronchial epithelial cells alone or respiratory syncytial virus
infection in combination with IFN-g treatment have been shown
to induce RANTES production in these cells in vitro (Olszewska-
Pazdrak et al, 1998). Besides IFN-g, IL-8, a proin¯ammatory and
neutrophil-attractant chemokine, has also been suggested to
mediate virus-induced exacerbation of asthma by recruiting
neutrophils into the site of allergic in¯ammation (Herz et al,
2000; Johnston et al, 1998; Harrison et al, 1999).
In conclusion we showed, that infection with in¯uenza A virus
induced a strong Th1 response with a minor Th2 component.
Furthermore, this is the ®rst report suggesting that virus-speci®c
IgE antibodies are produced, which can mediate mast cell
degranulation leading to allergic skin reactivity in mice. Beside a
possible role for the exacerbation of pre-existing atopic disease, this
®nding may provide one of the causative factors for the induction
of acute urticaria in humans following viral infections and warrants
further investigation.
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